Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New tool helps black and latina women weigh breast MRI options

NCT ID NCT06892275

First seen Jun 25, 2026 · Last updated Jun 25, 2026

Summary

This study tests a decision aid designed to help Black and Latina women at high risk for breast cancer make informed choices about whether to get a breast MRI in addition to their yearly mammogram. Eighty participants will be randomly assigned to receive either standard risk information plus a nurse referral, or that same information plus a detailed decision aid. The goal is to see if the decision aid helps women make choices that match their personal values and knowledge.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM FEMALE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Georgetown University

    RECRUITING

    Washington D.C., District of Columbia, 20007, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

decision aid (educational tool)

What this could lead to

If successful, this could help high-risk women make more informed, preference-based decisions about whether to add breast MRI to their annual mammogram.

What could go wrong

This is a small, early-stage behavioral study (80 participants) focused on decision-making, not on health outcomes. The results may not apply to other groups or settings.

Conditions

The condition(s) this trial relates to.

breast neoplasm hereditary breast ovarian cancer syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.